Amantadine Extended-Release Capsules and Omalizumab Subcutaneous
Determining the interaction of Amantadine Extended-Release Capsules and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: amantadine
Brand name: Gocovri, Osmolex ER, Symmetrel
Synonyms: Amantadine
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Amantadine Extended-Release Capsules-Ombitasvir, Paritaprevir, and Ritonavir
- Amantadine Extended-Release Capsules-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Amantadine Extended-Release Capsules-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Amantadine Extended-Release Capsules-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Amantadine Extended-Release Capsules-Omeclamox-Pak
- Amantadine Extended-Release Capsules-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Amantadine Extended-Release Tablets
- Omalizumab Subcutaneous-Amantadine Hydrochloride
- Omalizumab Subcutaneous-Amantadine Oral Solution USP
- Omalizumab Subcutaneous-Amantadine Syrup
- Omalizumab Subcutaneous-Amantadine Tablets
- Omalizumab Subcutaneous-Amaryl